医学
病态的
癌症
肌萎缩
无线电技术
重症监护医学
生物标志物
医学物理学
病理
内科学
放射科
生物化学
化学
作者
Roberto C. Delgado Bolton,Adriana K. Calapaquí Terán,Stefano Fanti,Francesco Giammarile
出处
期刊:Clinical Nuclear Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2022-08-04
卷期号:48 (2): 156-157
被引量:13
标识
DOI:10.1097/rlu.0000000000004357
摘要
Abstract Integrating clinical and pathological data together with imaging-derived information, such as radiomics and sarcopenia status, creating new combined biomarkers that increase the prognostic value compared with each of them used independently. The concept of strength through synergy, applicable in so many areas of life, is also demonstrated in this area of science and opens up innumerable pathways for improving patient care in cancer. This is as an example on how we can explore and make the most of all the information we already have (clinical, pathological, imaging), without the need for new invasive tests.
科研通智能强力驱动
Strongly Powered by AbleSci AI